Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Cardiff Oncology (CRDF) Long-Term Debt Issuances (2016)

Cardiff Oncology's Long-Term Debt Issuances history spans 4 years, with the latest figure at $7.0 million for Q4 2016.

  • For Q4 2016, Long-Term Debt Issuances changed N/A year-over-year to $7.0 million; the TTM value through Sep 2017 reached $7.0 million, up 785.18%, while the annual FY2020 figure was $305000.0, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q4 2016 was $7.0 million at Cardiff Oncology, up from $241954.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $14.5 million in Q2 2014 and bottomed at -$48637.0 in Q1 2014.
  • The 4-year median for Long-Term Debt Issuances is $2.3 million (2012), against an average of $2.7 million.
  • The largest YoY upside for Long-Term Debt Issuances was 4491.65% in 2014 against a maximum downside of 102.08% in 2014.
  • A 4-year view of Long-Term Debt Issuances shows it stood at $2.3 million in 2012, then changed by 0.0% to $2.3 million in 2013, then plummeted by 77.9% to $515964.0 in 2014, then soared by 1259.17% to $7.0 million in 2016.
  • Per Business Quant, the three most recent readings for CRDF's Long-Term Debt Issuances are $7.0 million (Q4 2016), $241954.0 (Q2 2016), and $550297.0 (Q1 2016).